SMTL ID : 4odf.1

Co-Crystal Structure of MDM2 with Inhibitor Compound 47

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x 2U1: 6-{[(2S,5R,6R)-4-[(1S)-2-(tert-butylsulfonyl)-1-cyclopropylethyl]-6-(3-chlorophenyl)-5-(4-chlorophenyl)-2-methyl-3-oxomorpholin-2-yl]methyl}pyridine-3-carboxylic acid(Non-covalent)

2U1.1: 14 residues within 4Å: Chain A: V.9, T.10, T.11, S.12, L.49, L.52, G.53, I.56, M.57, Y.62, V.88, H.91, I.94, Y.95 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:V.9, A:T.11, A:L.49, A:L.49, A:I.56, A:I.56, A:Y.62, A:V.88, A:V.88, A:I.94 Hydrogen bonds: A:S.12 Salt bridges: A:H.91 pi-Stacking: A:H.91, A:H.91 Halogen bonds: A:H.91

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gonzalez, A.Z. et al., Novel Inhibitors of the MDM2-p53 Interaction Featuring Hydrogen Bond Acceptors as Carboxylic Acid Isosteres. J.Med.Chem. (2014)

Release Date

2014-04-02

Peptides

E3 ubiquitin-protein ligase Mdm2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

E3 ubiquitin-protein ligase Mdm2

Related Entries With Identical Sequence